Select a Month...
Standing Together Against Hate
A letter from Seattle Children’s Leadership team addressing increasing acts of violence, xenophobia and hate against Asian and Pacific Islander communities,...
Seattle Children’s announces Andrew Lee as Vice President and Chief Equity, Diversity and Inclusion Officer to lead system-wide anti-racism and organizational change efforts
Today, following a national search, Seattle Children’s announced Andrew Lee will join the organization as Vice President and Chief Equity, Diversity and...
A message from Dr. Jeff Sperring
It has been our deeply held value and commitment at Seattle Children’s to provide a place where every child and family member feels valued, safe and seen and...
Seattle Children’s Assessment Committee Work is Underway; Committee Provides Process for Sharing Information
Statement from The Seattle Children’s Assessment Committee
Former U.S. Attorney General Eric Holder of Covington & Burling to lead examination of institutional racism, equity, inclusion, and diversity practices at Seattle Children’s
New community and board trustee members named to Assessment Committee
Seattle Children’s Commits to Rigorous Review of Race, Equity and Inclusion Practices
New board committee formed, will include community members and independent outside expert
Seattle Children’s Plans COVID-19 Vaccine Rollout
Today, Seattle Children’s received its first doses of Pfizer’s COVID-19 vaccine and will deploy its allocation in phases based on guidelines from the Centers...
Statement from Seattle Children’s on Main Campus Operating Rooms
We frequently test the air in every OR and can confirm the operating rooms at Seattle Children’s are safe.
GentiBio launches to develop engineered regulatory T cells for autoimmune and inflammatory diseases
Announces exclusive licensing partnerships for proprietary regulatory T cell engineering technologies with Seattle Children's Research Institute, Benaroya...
CSL Behring and Seattle Children’s Research Institute to Advance Gene Therapy Treatments for Primary Immunodeficiency Diseases
Initially, the alliance will develop treatment options for patients with two rare, life-threatening primary immunodeficiency diseases – Wiskott-Aldrich...